Atara Biotherapeutics ATRA
NASDAQ ATRA
$9.43 +0.08 (+0.86%)
At close: Oct 22, 2026 · 4:00 PM EDT

Atara Biotherapeutics (ATRA) EV to EBIT (2025)

Updated

Atara Biotherapeutics' (ATRA) EV to EBIT stood at 6.09 in Q4 2025, down 11.6% from the prior quarter.

Analysis

Atara Biotherapeutics (ATRA) EV to EBIT (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Atara Biotherapeutics 141.76 Mn 131.86 Mn 439,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 6.09
Sep 30, 2025 6.89
Jun 30, 2025 8.94
API Access

Atara Biotherapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=ATRA&period=max&api_key=YOUR_API_KEY